NeoGenomics, Inc. (NEO) Financials
NEO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.4 billion | 565.6 million |
| March 31, 2026 | 1.3 billion | 517.8 million |
| Dec. 31, 2025 | 1.4 billion | 523.3 million |
| Sept. 30, 2025 | 1.4 billion | 536.5 million |
NEO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 11.7 million | 8.2 million |
| March 31, 2026 | -13.1 million | 9.6 million |
| Dec. 31, 2025 | -6.5 million | 8.0 million |
| Sept. 30, 2025 | 570000 | 10.3 million |
NEO Net Income
No data available :(
NEO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 145.5 million | 374.2 million | 68.7 million |
| March 31, 2026 | 146.1 million | 342.2 million | 66.3 million |
| Dec. 31, 2025 | 159.6 million | 404.7 million | 62.8 million |
| Sept. 30, 2025 | 164.1 million | 341.5 million | 64.3 million |
NEO Shares Outstanding
NEO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 8.2 million | 10.8 million | 90.9 million | 27.3 million |
| March 31, 2026 | 5.0 million | 9.5 million | 89.6 million | 23.8 million |
| Dec. 31, 2025 | 7.9 million | 9.2 million | 87.0 million | 23.4 million |
| Sept. 30, 2025 | 8.3 million | 8.7 million | 91.7 million | 21.8 million |
NEO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 201.7 million | 109.8 million |
| March 31, 2026 | 186.7 million | 105.8 million |
| Dec. 31, 2025 | 190.2 million | 114.5 million |
| Sept. 30, 2025 | 187.8 million | 107.4 million |
NEO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NEO
Price: $17.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 437800
Ebitda: 2.2 millionMarket Capitalization: 446.6 million